[HTML][HTML] Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

E Jimenez-Solem, TS Petersen, C Hansen… - Scientific reports, 2021 - nature.com
Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We
hypothesized that machine learning (ML) models could be used to predict risks at different …

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

E Jimenez-Solem, TS Petersen, C Hansen… - Scientific …, 2021 - repub.eur.nl
Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We
hypothesized that machine learning (ML) models could be used to predict risks at different …

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients.

E Jimenez-Solem, TS Petersen, C Hansen… - Scientific …, 2021 - search.ebscohost.com
Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We
hypothesized that machine learning (ML) models could be used to predict risks at different …

[PDF][PDF] Developing and validating COVID‑19 adverse outcome risk prediction models from a bi‑national European cohort of 5594 patients

E Jimenez‑Solem, TS Petersen, C Hansen… - Scientific Reports, 2021 - pure.eur.nl
Methods All methods were carried out in accordance with relevant guidelines and
regulations. The study was approved by the relevant legal and ethics boards, including the …

DEVELOPING AND VALIDATING COVID-19 ADVERSE OUTCOME RISK PREDICTION MODELS FROM A BI-NATIONAL EUROPEAN COHORT OF 5594 PATIENTS

E Jimenez-Solem, TS Petersen, C Hansen, C Hansen… - medRxiv, 2020 - medrxiv.org
Background Patients with severe COVID-19 have overwhelmed healthcare systems
worldwide. We hypothesized that Machine Learning (ML) models could be used to predict …

[PDF][PDF] Developing and validating COVID‑19 adverse outcome risk prediction models from a bi‑national European cohort of 5594 patients

E Jimenez‑Solem, TS Petersen, C Hansen… - Scientific …, 2021 - skaftenicki.github.io
Methods All methods were carried out in accordance with relevant guidelines and
regulations. The study was approved by the relevant legal and ethics boards, including the …

[PDF][PDF] Developing and validating COVID‑19 adverse outcome risk prediction models from a bi‑national European cohort of 5594 patients

E Jimenez‑Solem, TS Petersen, C Hansen… - Scientific …, 2021 - academia.edu
Patients with severe COVID‑19 have overwhelmed healthcare systems worldwide. We
hypothesized that machine learning (ML) models could be used to predict risks at different …

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

E Jimenez-Solem, TS Petersen, C Hansen… - Scientific …, 2021 - ui.adsabs.harvard.edu
Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We
hypothesized that machine learning (ML) models could be used to predict risks at different …

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

E Jimenez-Solem, TS Petersen, C Hansen… - Scientific …, 2021 - research.regionh.dk
Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We
hypothesized that machine learning (ML) models could be used to predict risks at different …

[PDF][PDF] Developing and validating COVID‑19 adverse outcome risk prediction models from a bi‑national European cohort of 5594 patients

E Jimenez‑Solem, TS Petersen… - Scientific …, 2021 - regenhealthsolutions.info
Methods All methods were carried out in accordance with relevant guidelines and
regulations. The study was approved by the relevant legal and ethics boards, including the …